Literature DB >> 12955273

[Extravasation: a rare complication of central venous cannulation? Case report of an imminent erosion of the common carotid artery].

W Schummer1, C Schummer, A Müller, W Karzai.   

Abstract

Extravasation is the non-intentional leakage of substances/solutions into the perivascular or subcutaneous space that can result in significant tissue damage. The extent of destruction depends on the properties of the substance, its concentration, and the amount applied. Substances known to cause severe tissue damage include certain chemotherapeutic agents, vasoactive substances, concentrated electrolytes, and other hyperosmolar solutions. Extravasation can be avoided by meticulous monitoring of venous access. When extravasation occurs, the infusion should be stopped immediately. Substances known to cause tissue damage should be removed from perivascular or subcutaneous space within 24 hours by local incision and irrigation. A delay in early treatment may necessitate more extensive surgical debridement and skin coverage operations. Since the extent of deep soft tissue damage is difficult to predict and is often underestimated, a magnetic resonance imaging should be performed before surgery. We report here on a 73-year-old patient, in whom extravasation of potassium-chloride from a dislocated multi-lumen central venous catheter led to a life-threatening skin and soft-tissue necrosis of the neck. This article provides an overview of common vesicants, theories of tissue destruction, potential risk factors, guidelines for prevention, and current treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955273     DOI: 10.1007/s00101-003-0521-z

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  25 in total

Review 1.  Evaluation and treatment of chemotherapy extravasation injuries.

Authors:  E Kassner
Journal:  J Pediatr Oncol Nurs       Date:  2000-07       Impact factor: 1.636

2.  Skin necrosis from extravasation of intravenous fluids in children.

Authors:  A S Brown; D J Hoelzer; S A Piercy
Journal:  Plast Reconstr Surg       Date:  1979-08       Impact factor: 4.730

Review 3.  Fibrin sheath formation and chemotherapy extravasation: a case report.

Authors:  D J Mayo
Journal:  Support Care Cancer       Date:  1998-01       Impact factor: 3.603

4.  Antineoplastic vesicant extravasation.

Authors:  R Beason
Journal:  J Intraven Nurs       Date:  1990 Mar-Apr

5.  IV infiltration no clear signs, no clear treatment?

Authors:  M Hastings-Tolsma; C B Yucha
Journal:  RN       Date:  1994-12

Review 6.  Antidotes to vesicant chemotherapy extravasations.

Authors:  R T Dorr
Journal:  Blood Rev       Date:  1990-03       Impact factor: 8.250

7.  [Early and late treatment of iatrogenic injection damage].

Authors:  D von Heimburg; N Pallua
Journal:  Chirurg       Date:  1998-12       Impact factor: 0.955

Review 8.  Vesicant extravasation: myths and realities.

Authors:  D M Boyle; C Engelking
Journal:  Oncol Nurs Forum       Date:  1995 Jan-Feb       Impact factor: 2.172

9.  The use of hyaluronidase in the treatment of intravenous extravasation injuries.

Authors:  W V Raszka; T K Kueser; F R Smith; J W Bass
Journal:  J Perinatol       Date:  1990-06       Impact factor: 2.521

10.  Experience with subcutaneous infusion ports in three hundred patients.

Authors:  T E Brothers; L K Von Moll; J E Niederhuber; J A Roberts; S Walker-Andrews; W D Ensminger
Journal:  Surg Gynecol Obstet       Date:  1988-04
View more
  2 in total

Review 1.  Iatrogenic carotid artery injury in neurosurgery.

Authors:  Joji Inamasu; Bernard H Guiot
Journal:  Neurosurg Rev       Date:  2005-08-10       Impact factor: 3.042

Review 2.  Clinical Applications of Hyaluronidase.

Authors:  Gregor Cornelius Weber; Bettina Alexandra Buhren; Holger Schrumpf; Johannes Wohlrab; Peter Arne Gerber
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.